Veteran investment executive with experience in private equity and corporate finance, focused on growth-stage technology and healthcare investments. Joseph Morrison was previously a partner at a mid-market PE firm and has led cross-border M&A, portfolio operational turnarounds, and value-creation programs. Holds an MBA with earlier investment banking experience; active board member emphasising EBITDA improvement, capital-structure optimization and disciplined exit planning.
Veteran investment executive with experience in private equity and corporate finance, focused on growth-stage technology and healthcare investments. Joseph Morrison was previously a partner at a mid-market PE firm and has led cross-border M&A, portfolio operational turnarounds, and value-creation programs. Holds an MBA with earlier investment banking experience; active board member emphasising EBITDA improvement, capital-structure optimization and disciplined exit planning.
Brings a private-equity mindset to growth-stage technology and healthcare investing, prioritizing companies with durable unit economics and clear pathways to EBITDA improvement. Focuses on hands-on value creation—operational turnarounds, go-to-market scaling and capital‑structure optimization—combined with disciplined underwriting and exit planning. Leverages cross-border M&A and corporate‑finance experience to structure flexible, mid‑to‑long horizon investments that balance revenue growth with margin restoration. Prefers control or influential minority positions where board-level intervention can accelerate operational change and de‑risk outcomes.
Brings a private-equity mindset to growth-stage technology and healthcare investing, prioritizing companies with durable unit economics and clear pathways to EBITDA improvement. Focuses on hands-on value creation—operational turnarounds, go-to-market scaling and capital‑structure optimization—combined with disciplined underwriting and exit planning. Leverages cross-border M&A and corporate‑finance experience to structure flexible, mid‑to‑long horizon investments that balance revenue growth with margin restoration. Prefers control or influential minority positions where board-level intervention can accelerate operational change and de‑risk outcomes.
| Trades 825 | Longs Won 611/825 74% | Profit Factor 21.94 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $5.46M |
| Average Win $600,996.52 | Best Trade (Mar 31) $140.19M | Sharpe Ratio -21.94 |
| Average Loss -$78,192.56 | Worst Trade (Sep 30) -$6.79M | Z-Score 10.48 (100%) |
| Commissions $0 | Avg. Trade Length 1y 9m 2w 4d | Expectancy $424,818.99 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | 0.01% | 0.1% | 0.61% | 2.84% | 10.78% | 34.93% |
| Consecutive Losing Trades | 4,525 | 4,072 | 3,620 | 3,167 | 2,715 | 2,262 | 1,810 | 1,357 | 905 | 452 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
| 5952 59522J103 | 1,540 | $213,968 | $213,968 | - | - | - | 0.0 |
A Agilent Technologies Inc. | 2,246 | $310,711.93 | $333,598.38 | - | $22,886.45 | 7.37% | -0.509% |
AAPL Apple Inc. | 17,704 | $2.95M | $5.42M | - | $2.47M | 83.8% | +0.219% |
ABBV AbbVie Inc. | 8,169 | $1.29M | $2.04M | - | $747,125.03 | 57.88% | -0.542% |
ABT Abbott Laboratories | 6,724 | $680,872.59 | $748,045 | - | $67,172.41 | 9.87% | -0.018% |
ADP Automatic Data Processing Inc. | 26,667 | $5.97M | $7.28M | - | $1.31M | 21.85% | -1.184% |
AFL Aflac Inc. | 2,630 | $201,892.25 | $319,413.5 | - | $117,521.25 | 58.21% | +0.289% |
ALL Allstate Corporation | 2,534 | $357,305.92 | $662,412.94 | - | $305,107.02 | 85.39% | +0.357% |
AMAT Applied Materials, Inc. | 3,742 | $459,630 | $1.9M | - | $1.44M | 312.91% | -5.118% |
AMGN Amgen Inc. | 13,941 | $3.37M | $5.79M | - | $2.42M | 71.75% | -0.629% |
AMZN Amazon.com Inc | 2,812 | $333,312.56 | $738,571.77 | - | $405,259.21 | 121.59% | -0.935% |
AVGO Broadcom Inc. | 2,372 | $392,659.09 | $932,172.26 | - | $539,513.17 | 137.4% | -5.943% |
AXP American Express Company | 4,498 | $741,944.66 | $1.54M | - | $798,530.42 | 107.63% | -0.34% |
AZO AutoZone Inc. | 253 | $621,912 | $765,325 | - | $143,413 | 23.06% | -0.506% |
BAC Bank of America Corporation | 6,900 | $232,323.22 | $444,981 | - | $212,657.78 | 91.54% | +0.624% |
BMY Bristol-Myers Squibb Company | 17,273 | $1.19M | $1.1M | - | -$85,329.23 | -7.18% | -1.268% |
BP BP p.l.c. Sponsored ADR | 10,844 | $411,421.53 | $461,195.32 | - | $49,773.79 | 12.1% | -0.7% |
BR Broadridge Financial Solutions, Inc. | 7,388 | $1.08M | $1.26M | - | $180,563.01 | 16.67% | -0.714% |
BRK-B Berkshire Hathaway Inc. | 6,540 | $2.08M | $3.3M | - | $1.22M | 58.43% | -0.572% |
CARR Carrier Global Corporation | 4,310 | $197,182.05 | $270,581.8 | - | $73,399.75 | 37.22% | -0.9% |